drugset / Trial / NCT03702426

Comparison of the Efficacy of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Norfloxacin in Secondary Prophylaxis for Spontaneous Bacterial Peritonitis

NCT03702426

RandomizedParallel-groupDouble-blindTreatment

Summary

-Consecutive patients of decompensated cirrhosis of any etiology, presenting to the Institute of Liver and Biliary Sciences hospital with spontaneous bacterial peritonitis will be evaluated

Timeline

Start
2018-07-23
Primary completion
2019-07-31
Completion
2019-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject GMCSF Unknown 1.5 ug/kg
Background Norfloxacin Small molecule 400 mg Oral